Elevance Health, Inc. (ELV)
NYSE · Healthcare
Elevance Health, Inc. EBITDA 2007–2025
Elevance Health, Inc. annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Elevance Health, Inc. ebitda for the quarter ending March 31, 2026 was 2.4 B, a 31.13% decrease year-over-year.
- Elevance Health, Inc. ebitda for the twelve months ending March 31, 2026 was 10.4 B, a 7.62% decrease year-over-year.
- Elevance Health, Inc. annual ebitda for 2025 was 8.7 B, a 5.51% decrease from 2024.
- Elevance Health, Inc. annual ebitda for 2024 was 9.3 B, a 9.65% decrease from 2023.
- Elevance Health, Inc. annual ebitda for 2023 was 10.2 B, a 2.87% increase from 2022.
- Elevance Health, Inc. annual ebitda for 2022 was 10.0 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Elevance Health Inc. EBITDA — FAQ
Elevance Health Inc. (ELV) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELV's ebitda history?
The chart and table above show Elevance Health Inc.'s ebitda by year and by quarter, including the growth rate.